Comment on: 'EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update' by Gossec et al

被引：1
|
作者：
Wei, Chen-Yu [1 ]
Lee, Yung-Heng [2 ,3 ,4 ,5 ]
Wei, James Cheng Chung [6 ,7 ,8 ]
机构：
[1] Chung Shan Med Univ, Sch Med, Taichung, Taiwan
[2] China Med Univ, Dept Hlth Serv Adm, Taichung, Taiwan
[3] China Med Univ, Dept Publ Hlth, Taichung, Taiwan
[4] Minist Hlth & Welf, Cishan Hosp, Dept Orthoped, Kaohsiung, Taiwan
[5] Natl United Univ, Dept Ctr Gen Educ, Miaoli, Taiwan
[6] China Med Univ, Grad Inst Integrated Med, Taichung, Taiwan
[7] Chung Shan Med Univ Hosp, Dept Med, Taichung 402, Taiwan
[8] Chung Shan Med Univ, Inst Med, Taichung, Taiwan
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2022年 / 81卷 / 08期
关键词：
arthritis; psoriatic; autoimmune diseases; QUALITY-OF-LIFE;
D O I：
10.1136/annrheumdis-2020-218385
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Response to: Correspondence on 'EULAR recommendations for the management of systemic lupus erythematosus: 2023 update' by Fanouriakis et al
    Fanouriakis, Antonis
    Bertsias, George
    Boumpas, Dimitrios T.
    ANNALS OF THE RHEUMATIC DISEASES, 2024, 83 (11)
  • [32] Response to: Correspondence on 'EULAR recommendations for the management of systemic lupus erythematosus: 2023 update' by Fanouriakis et al
    Fanouriakis, Antonis
    Kostopoulou, Myrto
    Bertsias, George
    Boumpas, Dimitrios T.
    ANNALS OF THE RHEUMATIC DISEASES, 2024, 83 (10)
  • [33] Response to: Correspondence on 'EULAR recommendations for the management of systemic lupus erythematosus: 2023 update' by Fanouriakis et al
    Fanouriakis, Antonis
    Bertsias, George
    Boumpas, Dimitrios T.
    ANNALS OF THE RHEUMATIC DISEASES, 2024,
  • [34] Correspondence on 'EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update' by Hellmich et al
    Robson, Joanna C.
    Diaz Encarnacion, Montserrat M.
    Verhoeven, Peter
    Olivenza Anton, Raquel
    Balcells-Oliver, Monica
    Popov, Tamara
    Monti, Sara
    Kronbichler, Andreas
    ANNALS OF THE RHEUMATIC DISEASES, 2024, 83 (10)
  • [35] Management of rheumatoid arthritis in China: a study of the implementation of 2019 EULAR recommendations
    Jin, Shangyi
    Jiang, Nan
    Huo, Yuehong
    Duan, Xinwang
    Fang, Yongfei
    Zhao, Cheng
    Li, Hongbin
    Yang, Min
    Huang, Zhirao
    Yang, Pingting
    Zhang, Hongfeng
    Zhan, Feng
    Wang, Youlian
    Wang, Yanhong
    Wu, Chanyuan
    Wang, Qian
    Hsieh, Evelyn
    Li, Mengtao
    Tian, Xinping
    Zhao, Yan
    Zeng, Xiaofeng
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (07) : 1052 - 1054
  • [36] EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
    Smolen, Josef S.
    Landewe, Robert B. M.
    Bijlsma, Johannes W. J.
    Burmester, Gerd R.
    Dougados, Maxime
    Kerschbaumer, Andreas
    McInnes, Iain B.
    Sepriano, Alexandre
    van Vollenhoven, Ronald F.
    de Wit, Maarten
    Aletaha, Daniel
    Aringer, Martin
    Askling, John
    Balsa, Alejandro
    Boers, Maarten
    den Broeder, Alfons A.
    Buch, Maya H.
    Buttgereit, Frank
    Caporali, Roberto
    Cardiel, Mario Humberto
    De Cock, Diederik
    Codreanu, Catalin
    Cutolo, Maurizio
    Edwards, Christopher John
    van Eijk-Hustings, Yvonne
    Emery, Paul
    Finckh, Axel
    Gossec, Laure
    Gottenberg, Jacques-Eric
    Hetland, Merete Lund
    Huizinga, Tom W. J.
    Koloumas, Marios
    Li, Zhanguo
    Mariette, Xavier
    Mueller-Ladner, Ulf
    Mysler, Eduardo F.
    da Silva, Jose A. P.
    Poor, Gyula
    Pope, Janet E.
    Rubbert-Roth, Andrea
    Ruyssen-Witrand, Adeline
    Saag, Kenneth G.
    Strangfeld, Anja
    Takeuchi, Tsutomu
    Voshaar, Marieke
    Westhovens, Rene
    van der Heijde, Desiree
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (06) : 685 - 699
  • [37] Response to: '2016 update of the EULAR recommendations for the management of rheumatoid arthritis: no utopia for patients in low/middle-income countries?' by Misra et al
    Smolen, Josef S.
    Landewe, Robert B. M.
    van der Heijde, Desiree
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 (11)
  • [38] 2019 EULAR RECOMMENDATIONS FOR THE MANAGEMENT OF SJOGREN'S SYNDROME WITH TOPICAL AND SYSTEMIC THERAPIES
    Ramos-Casals, Manuel
    Brito-Zeron, Pilar
    Bombardieri, Stefano
    Bootsma, Hendrika
    De Vita, Salvatore
    Doerner, Thomas
    Fisher, Benjamin A.
    Gottenberg, Jacques-Eric
    Hernandez-Molina, Gabriela
    Kocher, Agnes
    Kostov, Belchin
    Kruize, Aike A.
    Mandl, Thomas
    Ng, Wan-Fai
    Retamozo, Soledad
    Seror, Raphaele
    Shoenfeld, Yehuda
    Siso-Almirall, Antoni
    Tzioufas, Athanasios G.
    Vitali, Claudio
    Bowman, Simon
    Mariette, Xavier
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 59 - 59
  • [39] Response to: Correspondence on 'EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update' by Hellmich et al
    Hellmich, Bernhard
    Jayne, David
    ANNALS OF THE RHEUMATIC DISEASES, 2024,
  • [40] 2019 update of the EULAR recommendations for the management of SLE: don't forget chloroquine
    Figueroa-Parra, Gabriel
    Magdalena Gamboa-Alonso, Carmen
    Laura De-Leon-Ibarra, Ana
    Angel Galarza-Delgado, Dionicio
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (09)
12345